Loading...
iNKT cells require TSC1 for terminal maturation and effector lineage fate decisions
Terminal maturation of invariant NKT (iNKT) cells from stage 2 (CD44(+)NK1.1(–)) to stage 3 (CD44(+)NK1.1(+)) is accompanied by a functional acquisition of a predominant IFN-γ–producing (iNKT-1) phenotype; however, some cells develop into IL-17–producing iNKT (iNKT-17) cells. iNKT-17 cells are rare...
Na minha lista:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society for Clinical Investigation
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3973110/ https://ncbi.nlm.nih.gov/pubmed/24614103 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI69780 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|